These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 37821203)
21. Monogenic autoinflammatory disorders: beyond the periodic fever. Moghaddas F Intern Med J; 2020 Feb; 50(2):151-164. PubMed ID: 31260149 [TBL] [Abstract][Full Text] [Related]
22. NF-κB and Related Autoimmune and Autoinflammatory Diseases. Freigeh GE; Michniacki TF Rheum Dis Clin North Am; 2023 Nov; 49(4):805-823. PubMed ID: 37821197 [TBL] [Abstract][Full Text] [Related]
23. A path towards personalized medicine for autoinflammatory and related diseases. Miner JJ; Fitzgerald KA Nat Rev Rheumatol; 2023 Mar; 19(3):182-189. PubMed ID: 36750685 [TBL] [Abstract][Full Text] [Related]
24. The expanding pathways of autoinflammation: a lesson from the first 100 genes related to autoinflammatory manifestations. Papa R; Picco P; Gattorno M Adv Protein Chem Struct Biol; 2020; 120():1-44. PubMed ID: 32085880 [TBL] [Abstract][Full Text] [Related]
25. Broadening the definition of autoinflammation. Masters SL Semin Immunopathol; 2015 Jul; 37(4):311-2. PubMed ID: 25994947 [TBL] [Abstract][Full Text] [Related]
26. The Interactions Between Autoinflammation and Type 2 Immunity: From Mechanistic Studies to Epidemiologic Associations. Sylvester M; Son A; Schwartz DM Front Immunol; 2022; 13():818039. PubMed ID: 35281022 [TBL] [Abstract][Full Text] [Related]
27. Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Lopalco G; Cantarini L; Vitale A; Iannone F; Anelli MG; Andreozzi L; Lapadula G; Galeazzi M; Rigante D Mediators Inflamm; 2015; 2015():194864. PubMed ID: 25784780 [TBL] [Abstract][Full Text] [Related]
28. Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics. Melki I; Frémond ML Curr Rheumatol Rep; 2020 Jun; 22(7):32. PubMed ID: 32548765 [TBL] [Abstract][Full Text] [Related]
29. Introduction to autoinflammatory syndromes and diseases. Abramovits W; Oquendo M Dermatol Clin; 2013 Jul; 31(3):363-85. PubMed ID: 23827242 [TBL] [Abstract][Full Text] [Related]
30. Controlling inflammation: contemporary treatments for autoinflammatory diseases and syndromes. Sterba G; Sterba Y Dermatol Clin; 2013 Jul; 31(3):507-11. PubMed ID: 23827252 [TBL] [Abstract][Full Text] [Related]
31. The everchanging framework of autoinflammation. Manna R; Rigante D Intern Emerg Med; 2021 Oct; 16(7):1759-1770. PubMed ID: 33999387 [TBL] [Abstract][Full Text] [Related]
32. Crosstalk between Interleukin-1β and Type I Interferons Signaling in Autoinflammatory Diseases. Georgel P Cells; 2021 May; 10(5):. PubMed ID: 34066649 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic Approaches to Type I Interferonopathies. Bienias M; Brück N; Griep C; Wolf C; Kretschmer S; Kind B; Tüngler V; Berner R; Lee-Kirsch MA Curr Rheumatol Rep; 2018 Apr; 20(6):32. PubMed ID: 29679241 [TBL] [Abstract][Full Text] [Related]
38. Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Goldbach-Mansky R Clin Exp Immunol; 2012 Mar; 167(3):391-404. PubMed ID: 22288582 [TBL] [Abstract][Full Text] [Related]
39. [Classification of autoinflammatory diseases based on pathophysiological mechanisms]. Kallinich T; Hinze C; Wittkowski H Z Rheumatol; 2020 Sep; 79(7):624-638. PubMed ID: 32394046 [TBL] [Abstract][Full Text] [Related]
40. From autoinflammation to autoimmunity: old and recent findings. Caso F; Costa L; Nucera V; Barilaro G; Masala IF; Talotta R; Caso P; Scarpa R; Sarzi-Puttini P; Atzeni F Clin Rheumatol; 2018 Sep; 37(9):2305-2321. PubMed ID: 30014358 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]